RecoveryPad telehealth care for opioid use disorder
About this title
Read the official source — NCT07362082Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
Adults with moderate or severe opioid use disorder may be eligible for this randomized study in Connecticut. Participants are assigned to RecoveryPad, a telehealth platform, or treatment as usual, which includes referrals to harm-reduction and community resources. Eligibility requires English and access to a phone or web-enabled device. The registry excludes people currently taking medication for opioid use disorder, among others; do not stop or change prescribed treatment based on this summary. The study will assess the platform; its benefit is not established.
- Listed locations
- New HavenSee all locations and recruitment
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 470
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07362082
- Official title
Show the full official title
A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders
Recruitment & locations
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
